Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Haese

Showing results (171-180 of 214) with videos related to

Pageof 22
Sort By:
BMC Medical Research Methodology|July 21, 2022
Accommodating heterogeneous missing data patterns for prostate cancer risk predictionMatthias Neumair, Michael W Kattan, Stephen J Freedland, et al.
BJU International|March 17, 2010
The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies?Guillaume Ploussard, Alexander Haese, Hendrik Van Poppel, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 25, 2021
Overexpression of the TRIM24 E3 Ubiquitin Ligase is Linked to Genetic Instability and Predicts Unfavorable Prognosis in Prostate CancerDoris Höflmayer, Christoph Fraune, Claudia Hube-Magg, et al.
European Urology|March 24, 2009
Prostate cancer gene 3 (PCA3): development and internal validation of a novel biopsy nomogramFelix K Chun, Alexandre de la Taille, Hendrik van Poppel, et al.
BJU International|July 6, 2013
Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS projectMassimo Lazzeri, Alexander Haese, Alberto Abrate, et al.
Aging|September 27, 2019
Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancerStefan Steurer, Benjamin Hager, Franziska Büscheck, et al.
The Journal of Urology|August 21, 2010
Biochemical recurrence after radical prostatectomy: multiplicative interaction between surgical margin status and pathological stageLars Budäus, Hendrik Isbarn, Christian Eichelberg, et al.
Pathology|April 23, 2020
High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancerTill Eichenauer, Felix Federlein, Katharina Möller, et al.
BJU International|August 2, 2006
Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validationFelix K-H Chun, Alberto Briganti, Shahrokh F Shariat, et al.
Virchows Archiv : an International Journal of Pathology|May 18, 2020
Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancersKatharina Möller, Anna Lena Wecker, Doris Höflmayer, et al.
Pageof 22

Showing results (171-180 of 214) with videos related to

Sort By:
Pageof 22
BMC Medical Research Methodology|July 21, 2022
Accommodating heterogeneous missing data patterns for prostate cancer risk predictionMatthias Neumair, Michael W Kattan, Stephen J Freedland, et al.
BJU International|March 17, 2010
The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies?Guillaume Ploussard, Alexander Haese, Hendrik Van Poppel, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 25, 2021
Overexpression of the TRIM24 E3 Ubiquitin Ligase is Linked to Genetic Instability and Predicts Unfavorable Prognosis in Prostate CancerDoris Höflmayer, Christoph Fraune, Claudia Hube-Magg, et al.
European Urology|March 24, 2009
Prostate cancer gene 3 (PCA3): development and internal validation of a novel biopsy nomogramFelix K Chun, Alexandre de la Taille, Hendrik van Poppel, et al.
BJU International|July 6, 2013
Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS projectMassimo Lazzeri, Alexander Haese, Alberto Abrate, et al.
Aging|September 27, 2019
Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancerStefan Steurer, Benjamin Hager, Franziska Büscheck, et al.
The Journal of Urology|August 21, 2010
Biochemical recurrence after radical prostatectomy: multiplicative interaction between surgical margin status and pathological stageLars Budäus, Hendrik Isbarn, Christian Eichelberg, et al.
Pathology|April 23, 2020
High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancerTill Eichenauer, Felix Federlein, Katharina Möller, et al.
BJU International|August 2, 2006
Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validationFelix K-H Chun, Alberto Briganti, Shahrokh F Shariat, et al.
Virchows Archiv : an International Journal of Pathology|May 18, 2020
Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancersKatharina Möller, Anna Lena Wecker, Doris Höflmayer, et al.
Pageof 22